Contemporary optimized practice in the management of pulmonary sarcoidosis Tekijä Shambhu Aryal, Steven D. Nathan

Hae kokoteksti

Clinical implications of six-minute walk test in patients with idiopathic pulmonary fibrosis: a retrospective cohort study Tekijä Min Jee Kim, Steven D. Nathan, Hyeon Hwa Kim, Ho Cheol Kim

Hae kokoteksti

Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis Tekijä Tracey Weiss, Aimee M. Near, Xiaohui Zhao, Dena Rosen Ramey, Tania Banerji, Handing Xie, Steven D. Nathan

Hae kokoteksti

The 6-min walk test as a primary end-point in interstitial lung disease Tekijä Sergio Harari, Athol U. Wells, Wim A. Wuyts, Steven D. Nathan, Klaus-Uwe Kirchgaessler, Monica Bengus, Jürgen Behr

Hae kokoteksti

Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Dev... Tekijä Steven D. Nathan, Peter Fernandes, Mitchell Psotka, Patrizio Vitulo, Lucilla Piccari, Katerina Antoniou, Sylvia M. Nikkho, Norman Stockbridge

Hae kokoteksti

COPD associated pulmonary hypertension: A post hoc analysis of the PERFECT study Tekijä Steven D. Nathan, Victoria Lacasse, Heidi Bell, Prakash Sista, Michael Di Marino, Todd Bull, Victor Tapson, Aaron Waxman

Hae kokoteksti

Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database Tekijä Steven D. Nathan, Scott D. Barnett, Christopher S. King, Steeve Provencher, Joan A. Barbera, Jean Pastre, Oksana A. Shlobin, Werner Seeger

Hae kokoteksti

HRCT evaluation of patients with interstitial lung disease: comparison of the 2018 and 2011 diagnostic guidelines Tekijä Steven D. Nathan, Jean Pastre, Inga Ksovreli, Scott Barnett, Christopher King, Shambhu Aryal, Kareem Ahmad, Cesar Fukuda, Vijaya Ramalingam, Jonathan H. Chung

Hae kokoteksti

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Inn... Tekijä Oksana A. Shlobin, Eric Shen, Stephen J. Wort, Lucilla Piccari, John A. Scandurra, Paul M. Hassoun, Sylvia M. Nikkho, Steven D. Nathan

Hae kokoteksti

Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real‐world data analysis Tekijä Tracey Weiss, Dena R. Ramey, Ngan Pham, Nazneen Fatima Shaikh, Dajun Tian, Xiaohui Zhao, Aimee M. Near, Dominik Lautsch, Steven D. Nathan

Hae kokoteksti

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis Tekijä Vincent Cottin, Steven D Nathan, Lisa Lancaster, Peter Smith, Kevin R Flaherty, Jürgen Behr, CQ Deng, Natalie Pearce, Heidi Bell, Leigh Peterson

Hae kokoteksti

Prevalence of pulmonary hypertension in patients with COVID‐19 related lung disease listed for lung transplantation: A UNOS registry analysis Tekijä Christopher Thomas, Abhimanyu Chandel, Christopher S. King, Shambhu Aryal, A. Whitney Brown, Vikramjit Khangoora, Alan Nyquist, Anju Singhal, Onix Cantres Fonseca, Oksana Shlobin, Steven D. Nathan

Hae kokoteksti

External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis Tekijä Abhimanyu Chandel, Christopher S. King, Rosalinda V. Ignacio, Jean Pastre, Oksana A. Shlobin, Vikramjit Khangoora, Shambhu Aryal, Alan Nyquist, Anju Singhal, Kevin R. Flaherty, Steven D. Nathan

Hae kokoteksti

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository Tekijä Harrison W. Farber, Murali M. Chakinala, Michelle Cho, Robert P. Frantz, Andrew Frick, Lisa Lancaster, Scott Milligan, Ronald Oudiz, Sumeet Panjabi, Yuen Tsang, Steven D. Nathan

Hae kokoteksti

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease Tekijä Toby M. Maher, Courtney Schiffman, Michael Kreuter, Catharina C. Moor, Steven D. Nathan, Judit Axmann, Paula Belloni, Monica Bengus, Frank Gilberg, Klaus-Uwe Kirchgaessler, Marlies S. Wijsenbeek

Hae kokoteksti

Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension Tekijä Abhimanyu Chandel, Alison Verster, Husna Rahim, Vikramjit Khangoora, Steven D. Nathan, Kareem Ahmad, Shambhu Aryal, Aaron Bagnola, Anju Singhal, A. Whitney Brown, Oksana A. Shlobin, Christopher S. King

Hae kokoteksti

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Inst... Tekijä Lucilla Piccari, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan, Stephen John Wort

Hae kokoteksti

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis Tekijä Lisa H. Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler, Ulrich Costabel

Hae kokoteksti

Discrepancy between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in patients with interstitial lung disease Tekijä Ho Cheol Kim, MD, Onix Cantres Fonseca, MD, Behnam N. Tehrani, MD, Christopher S. King, MD, Christopher Thomas, MD, Vikramjit Khangoora, MD, Oksana A. Shlobin, MD, Steven D. Nathan, MD

Hae kokoteksti

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry Tekijä Christopher S. King, Emily White, Shambhu Aryal, Oksana A. Shlobin, Anju Singhal, A. Whitney Brown, Christopher Thomas, Vikramjit Khangoora, Alan Nyquist, Kevin R. Flaherty, Steven D. Nathan, Joshua J. Mooney

Hae kokoteksti